Patent · US Active

Compositions and methods for treating anemia

US11844756B2 · kind B2 · utility

0Cited by

39References

18Claims

0Family size

Assignee

Akebia Therapeutics, Inc. · US

Inventors

Alexander Smith · Apex, US
Gurudatt Chandorkar · Waltham, US
Ene Ette · Framingham, US
Bradley John Maroni · Boston, US
Charlotte Suzanne Hartman · Carmel, US
Ramin Farzaneh-Far · Brookline, US
Jula Kern Inrig · Yorba Linda, US

Key dates

Filing date	Apr 4, 2022
Grant date	Dec 19, 2023
Priority date	—
Expiry date	Apr 4, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D213/81
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are specific doses of, and dosing regimens for, using a HIF prolyl hydroxylase inhibitor in treating or preventing anemia, such as anemia secondary to or associated with chronic kidney disease, anemia secondary to or associated with non-dialysis dependent chronic kidney disease anemia associated with or resulting from chemotherapy, or anemia associated with AIDS.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.